18
Participants
Start Date
January 31, 2009
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2013
D-serine
6 week fixed dose phase with D-serine 1500 mg/day to be increased starting from week two to 3000 mg/day followed by a 4 week flexible dose phase allowing for two 500 mg/day dose changes
Olanzapine
6 week fixed dose phase with Olanzapine 15 mg/day to be increased starting from week two to 30 mg/day followed by a 4 week flexible dose phase allowing for two 5 mg/day dose changes.
Ezrath Nashim - Herzog Memorial Hospital, Jerusalem
Collaborators (1)
Israel Science Foundation
OTHER
Herzog Hospital
OTHER